• English
    • German

Team

Meet the Team

Wolfgang Hierneis
Managing Director
Dr. Helge W. Thies
Research and Development
Dr. Markus Klemke
Laboratory
Uwe Jensen
Managing Director
Ralf Grundmann
Business Development

Breaking new ground for
diagnostics, therapeutics and prevention

Diagnostics

mRNA-analysis of the SAT offers deep and completely new insights into the energy metabolism. Especially with metabolic diseases the current dynamics of the body and influences over life-time play a far greater role than genetic dispositions

Read more

Therapeutics

The key to successful treatment of metabolic diseases lies in the intervention with disease-causing on-going biological processes. As the mRNA of the SAT are to a great extent the drivers of pathology of these diseases, they offer a strong lever for therapy.

Read more

Prevention

A great advantage of mRNA-analysis of the subcutaneous adipose tissue lies in the very early detection of unhealthy developments of the metabolism long before any signs can be seen in blood-analysis or any symptoms become apparent. It is, therefore, a powerful component in preventive personalised medicine.

Read more